Abstract WP204: Genetic Variant in VCAM1 Mediates Acute Infarct Size in Ischemic Stroke Patients
Introduction: Even though neuroinflammation is increasingly recognized as an essential contributor to ischemic brain injury, the exact underlying mechanisms remain unclear. Higher expression of the vascular cell adhesion molecule 1 (VCAM-1) increases leukocyte-brain endothelium interaction and has been associated with larger infarct size following acute ischemic stroke (AIS). The activation of the TGF-β signaling pathways can down-regulate VCAM-1 expression and ameliorate deleterious tissue outcome during neuroinflammation.
Hypothesis: We sought to investigate whether genetic variation in the TGF-beta pathway and adhesion molecule genes is associated with acute stroke lesion size.
Methods: We completed genome-wide association (GWA) testing and diffusion-weighted imaging lesion volume (DWIv) analysis in a discovery cohort of 532 AIS patients of European ancestry enrolled within 48 hours of symptom onset. An independent European ancestry cohort of 724 AIS patients with GWA data and automated DWIv served as replication cohort. GWA testing per SNP was performed using linear regression modeling of natural log-transformed DWIv adjusted for age, sex and relevant principal components. We selected 42 inflammatory genes in the TGF-beta pathway for a gene-based analysis using VEGAS (Versatile Gene-based -Association Study) software. A pre-specified discovery phase Bonferroni-corrected threshold was set at p<0.001. In the replication phase, 14 SNPs overlapping were tested at the Bonferroni-corrected p-value threshold of p<0.004.
Results: Of all genes in the TGF-beta pathway, VCAM1 (p=0.0006) was significantly associated with DWIv in the discovery AIS cohort (age: 66 ± 14.9 years, sex: 63.4% male, DWIv: 2.2cm3 (IQR: 0.6-11.7cm3)). A single SNP within the VCAM1 gene boundaries (rs3176876 (BETA=0.2341, p=0.003)) was significantly associated with DWIv in the replication AIS cohort (age: 65 ± 14.1 years, sex: 68.6% male, DWIv: 4cm3 (IQR: 1.3-17.2cm3)).
Conclusion: The genetic variant rs3176876 in the VCAM1 gene is associated with larger infarct lesion size measured on brain MRI of AIS patients. These findings suggest genetic contribution to the pro-inflammatory mechanisms in acute cerebral ischemia and warrant further investigation.
Author Disclosures: A. Giese: None. P. Musolino: None. H. Xu: None. K. Ryan: None. M.D. Schirmer: None. A.V. Dalca: None. J.W. Cole: None. P.F. McArdle: None. J.P. Broderick: Other Research Support; Modest; Genentech - monies to department for my role on Executive Committee of PRISMS Trial. Other Research Support; Significant; Modest. J. Jimenez-Conde: None. C. Jern: None. B.M. Kissela: None. D.O. Kleindorfer: None. R. Lemmens: None. A. Lindgren: None. J.F. Meschia: Research Grant; Significant; NIH-NINDS research grant: U01 NS069208. T. Rundek: Research Grant; Significant; NIH-NINDS research grant: U01 NS069208. R.L. Sacco: Research Grant; Modest; Boehringer Ingelheim for RESPECT ESUS trial. R. Schmidt: None. P. Sharma: None. A. Slowik: None. V. Thijs: None. D. Woo: Research Grant; Significant; NIH-NINDS research grant: U01 NS069208. B.B. Worrall: Research Grant; Significant; NIH-NINDS research grant: U01 NS069208. Other; Modest; Deputy Editor of Neurology. P. Golland: Research Grant; Significant; NIH-NIBIB research grant: P41EB015902. S.J. Kittner: Research Grant; Significant; NIH-NINDS research grant: U01 NS069208. J. Rosand: Research Grant; Significant; NIH-NINDS research grant: U01 NS069208. B.D. Mitchell: None. O. Wu: Research Grant; Significant; NIH-NINDS research grants: R01NS059775, R01NS063925, R01NS082285, P50NS051343, R01NS086905, U01 NS069208. Consultant/Advisory Board; Modest; Penumbra. N.S. Rost: Research Grant; Significant; NIH-NINDS research grants: R01NS086905, K23NS064052, R01NS082285.
- © 2017 by American Heart Association, Inc.